Healthcare Realty Trust (NYSE:HR) Reaches New 12-Month High - Here's What Happened

Key Points

• Healthcare Realty Trust achieved a new 52-week high with shares trading at $18.84, reflecting increased investor interest, as evidenced by the trading volume of 4,919 shares.
• Scotiabank upgraded the stock's rating to "sector outperform" and increased the price target from $18.00 to $20.00, indicating optimistic market sentiment.
• The company recently disclosed a dividend payout ratio of -83.48%, despite issuing a quarterly dividend of $0.24 per share, highlighting financial challenges.

Shares of Healthcare Realty Trust Incorporated (NYSE:HR - Get Free Report) hit a new 52-week high during mid-day trading on Monday . The stock traded as high as $18.84 and last traded at $18.75, with a volume of 4919 shares changing hands. The stock had previously closed at $18.60.

Analyst Upgrades and Downgrades

HR has been the topic of several research analyst reports. Weiss Ratings reiterated a "sell (d+)" rating on shares of Healthcare Realty Trust in a research report on Wednesday, October 8th. Scotiabank upgraded Healthcare Realty Trust from a "sector perform" rating to a "sector outperform" rating and lifted their price target for the company from $18.00 to $20.00 in a research report on Friday, September 5th. Royal Bank Of Canada initiated coverage on Healthcare Realty Trust in a research report on Wednesday, October 8th. They set a "sector perform" rating and a $19.00 price target on the stock. BTIG Research reiterated a "buy" rating and set a $20.00 price target on shares of Healthcare Realty Trust in a research report on Monday, September 29th. Finally, JPMorgan Chase & Co. lowered their price target on Healthcare Realty Trust from $18.00 to $17.00 and set a "neutral" rating on the stock in a research report on Thursday, June 26th. Three investment analysts have rated the stock with a Buy rating, five have issued a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of "Hold" and a consensus target price of $18.75.

Healthcare Realty Trust Price Performance

The firm has a market cap of $6.61 billion, a PE ratio of -16.34 and a beta of 0.96. The business has a fifty day moving average price of $17.63 and a two-hundred day moving average price of $16.22.

Healthcare Realty Trust (NYSE:HR - Get Free Report) last issued its quarterly earnings results on Thursday, July 31st. The real estate investment trust reported $0.41 earnings per share for the quarter, beating analysts' consensus estimates of $0.40 by $0.01. Healthcare Realty Trust had a negative return on equity of 7.70% and a negative net margin of 32.95%.The business had revenue of $287.07 million for the quarter, compared to the consensus estimate of $290.83 million. During the same quarter in the previous year, the company posted $0.38 earnings per share. Healthcare Realty Trust has set its FY 2025 guidance at 1.570-1.610 EPS. As a group, sell-side analysts forecast that Healthcare Realty Trust Incorporated will post 1.59 EPS for the current fiscal year.

Healthcare Realty Trust Cuts Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, August 28th. Investors of record on Thursday, August 14th were given a dividend of $0.24 per share. The ex-dividend date of this dividend was Thursday, August 14th. This represents a $0.96 dividend on an annualized basis and a yield of 5.1%. Healthcare Realty Trust's dividend payout ratio (DPR) is presently -83.48%.

Insider Transactions at Healthcare Realty Trust

In other Healthcare Realty Trust news, Director Thomas N. Bohjalian acquired 10,000 shares of the company's stock in a transaction dated Wednesday, August 13th. The shares were acquired at an average cost of $16.46 per share, for a total transaction of $164,600.00. Following the completion of the purchase, the director owned 75,520 shares of the company's stock, valued at approximately $1,243,059.20. This trade represents a 15.26% increase in their position. The purchase was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, EVP Julie F. Wilson sold 15,000 shares of Healthcare Realty Trust stock in a transaction dated Friday, September 5th. The stock was sold at an average price of $18.00, for a total value of $270,000.00. Following the completion of the transaction, the executive vice president owned 113,419 shares in the company, valued at $2,041,542. The trade was a 11.68% decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.37% of the stock is owned by insiders.

Hedge Funds Weigh In On Healthcare Realty Trust

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Ethic Inc. increased its stake in Healthcare Realty Trust by 52.8% during the third quarter. Ethic Inc. now owns 40,002 shares of the real estate investment trust's stock valued at $721,000 after acquiring an additional 13,826 shares during the period. CWM LLC increased its stake in Healthcare Realty Trust by 220.2% during the third quarter. CWM LLC now owns 70,415 shares of the real estate investment trust's stock valued at $1,270,000 after acquiring an additional 48,424 shares during the period. Pacer Advisors Inc. bought a new position in Healthcare Realty Trust during the third quarter valued at about $1,237,000. Brighton Jones LLC bought a new position in Healthcare Realty Trust during the third quarter valued at about $255,000. Finally, GAMMA Investing LLC increased its stake in Healthcare Realty Trust by 40.0% during the third quarter. GAMMA Investing LLC now owns 7,942 shares of the real estate investment trust's stock valued at $143,000 after acquiring an additional 2,270 shares during the period.

About Healthcare Realty Trust

Healthcare Realty Trust, Inc provides real estate investment services. It owns, leases, manages, acquires, finances, develops, and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States of America. The company was founded by David R.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.